Senior Manager, Clinical Trial Accounting jobs in United States
cer-icon
Apply on Employer Site
company-logo

Mirum Pharmaceuticals, Inc. · 1 day ago

Senior Manager, Clinical Trial Accounting

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. The Senior Manager, Clinical Trials Accounting is responsible for overseeing the accounting, financial close, and reporting activities related to clinical trial programs, ensuring compliance with US GAAP and strong internal controls over clinical trial expenditures.

BiotechnologyHealth CarePharmaceuticalTherapeutics

Responsibilities

Oversee accounting for clinical trial costs, including CROs, investigator costs, and pass-through costs
Prepare and review monthly clinical trial accruals using patient-based, milestone-based, and activity-based methodologies
Ensure timely and accurate close of clinical trial-related accounts as part of the monthly and quarterly close process
Maintain detailed supporting documentation and reconciliations for clinical accruals
Perform high quality, accurate financial and operational analysis for different categories of costs within Clinical Operations over various periods to explain fluctuations and ensure it aligns with clinical trial activity
Partner closely with the Project Managers (PMs) in Clinical Operations and CROs to understand trial status, enrollment, milestones, and contract terms
Lead and facilitate recurring meetings with PMs and CROs to obtain required accounting information for monthly/quarterly close
Review clinical contracts for accounting implications
Act as the finance point of contact for clinical teams on accounting-related matters
Ensure compliance with US GAAP, internal accounting policies, and SOX/internal control requirements
Support internal and external audits by preparing audit schedules and responding to inquiries related to clinical trial costs
Identify and implement process improvements to strengthen controls, efficiency, and scalability
Drive enhancements to accrual models, reporting, and automation as the clinical portfolio grows
Support implementation or optimization of systems related to clinical trial accounting and tracking

Qualification

US GAAPClinical trial accountingCRO/vendor contractsMicrosoft Office SuiteAccounting softwareCPAAnalytical skillsCommunication skillsTeam playerDetail oriented

Required

Strong US GAAP knowledge as it relates to R&D and clinical trial accounting
Minimum 8 years of related accounting experience, including working knowledge of clinical trials accounting in biotech or pharmaceutical companies
Hands-on experience with clinical accruals, CRO/vendor contracts, and complex trial structures
Advanced knowledge of Microsoft Office Suite, especially Excel
Hands-on experience in managing general ledger related functions, including familiarity with accounting software such as NetSuite or similar (NetSuite experience a plus)
Bachelor or master's degree in accounting
A sense of ownership and pride in your performance and its impact on the company's success
A positive, self-confident and decisive work ethic with excellent communication skills in both oral and written formats, as well as excellent listening skills
Self-motivated and self-managed - able to think independently and creatively
Ability to build and scale processes with strong analytical skills
Energy to commit to a fast-paced environment; ability to manage multiple priorities
Must be detail oriented yet not lost in the details
A team player and able to support other departments to achieve objectives
Proactive, hands-on mindset with a continuous improvement orientation

Preferred

CPA preferred

Company

Mirum Pharmaceuticals, Inc.

twittertwittertwitter
company-logo
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults.

Funding

Current Stage
Public Company
Total Funding
$765.5M
Key Investors
TCG CrossoverOberland CapitalNew Enterprise Associates
2025-12-19Post Ipo Equity· $68.5M
2025-12-08Post Ipo Equity· $200M
2023-04-12Post Ipo Equity· $275M

Leadership Team

leader-logo
Joanne Quan
Chief Medical Officer
linkedin
Company data provided by crunchbase